BioCentury
ARTICLE | Clinical News

CVT-1: Began Phase I trial

February 14, 1994 8:00 AM UTC

CV Therapeutics Inc., Mountain View, Calif. Product: CVT-1 orally active sulfated polysaccharide that blocks a transport protein that carries cholesterol across the intestine Indication: High serum ch...